These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 22897996
1. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. Vucic E, Calcagno C, Dickson SD, Rudd JH, Hayashi K, Bucerius J, Moshier E, Mounessa JS, Roytman M, Moon MJ, Lin J, Ramachandran S, Tanimoto T, Brown K, Kotsuma M, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2012 Aug; 5(8):819-28. PubMed ID: 22897996 [Abstract] [Full Text] [Related]
2. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, Mounessa JS, Roytman M, Moon MJ, Lin J, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870 [Abstract] [Full Text] [Related]
3. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083 [Abstract] [Full Text] [Related]
4. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA. Atherosclerosis; 2013 Jun 03; 228(2):339-45. PubMed ID: 23582588 [Abstract] [Full Text] [Related]
5. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH, Tian P, Xu JP, Wang ZZ, Zhao XZ, Nie MX, Zhang MD, Zhao QM, Zhao BT, Song SJ. Zhonghua Nei Ke Za Zhi; 2019 Nov 01; 58(11):808-813. PubMed ID: 31665855 [Abstract] [Full Text] [Related]
6. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor. Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, Fayad ZA. JACC Cardiovasc Imaging; 2018 Feb 01; 11(2 Pt 2):291-301. PubMed ID: 29413439 [Abstract] [Full Text] [Related]
7. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T. Clin Ther; 2010 Dec 01; 32(14):2337-47. PubMed ID: 21353104 [Abstract] [Full Text] [Related]
12. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. Atherosclerosis; 2015 Jun 01; 240(2):490-6. PubMed ID: 25913664 [Abstract] [Full Text] [Related]
13. In vivo evaluation of atherosclerotic plaque inflammation and of anti-inflammatory effects of statins by 18F-fluorodeoxyglucose positron emission tomography. Gerber BL. J Am Coll Cardiol; 2013 Sep 03; 62(10):918-20. PubMed ID: 23727087 [No Abstract] [Full Text] [Related]
15. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. J Nucl Med; 2009 Jun 03; 50(6):959-65. PubMed ID: 19443582 [Abstract] [Full Text] [Related]
16. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JHF, Fayad ZA, Van Dyke TE, Tawakol A. J Am Coll Cardiol; 2013 Dec 24; 62(25):2382-2391. PubMed ID: 24070911 [Abstract] [Full Text] [Related]
17. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. J Vis Exp; 2012 May 02; (63):e3777. PubMed ID: 22588186 [Abstract] [Full Text] [Related]
18. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, Wang YC, Lin YH, Lin HJ, Tzen KY, Yen RF, Chi YC, Huang PJ, Yang WS. Eur J Nucl Med Mol Imaging; 2012 Mar 02; 39(3):399-407. PubMed ID: 22109668 [Abstract] [Full Text] [Related]